Education
About Us
Working with TipRanks
Follow Us
Pharmaust Limited (AU:NUZ)
ASX:NUZ
Total Valuation
Pharmaust Limited has a market cap or net worth of AU$64.73M. The enterprise value is AU$60.57M.
Market CapAU$64.73M
Enterprise ValueAU$60.57M
Share Statistics
Pharmaust Limited has 688,628,660 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding688,628,660
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharmaust Limited’s return on equity (ROE) is -5.88 and return on invested capital (ROIC) is -653.88%.
Return on Equity (ROE)-5.88
Return on Assets (ROA)-3.81
Return on Invested Capital (ROIC)-653.88%
Return on Capital Employed (ROCE)-6.54
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pharmaust Limited is ―. Pharmaust Limited’s PEG ratio is -0.08.
PE Ratio―
PS Ratio0.00
PB Ratio25.24
Price to Fair Value25.24
Price to FCF-4.98
Price to Operating Cash Flow-3.02
PEG Ratio-0.08
Income Statement
In the last 12 months, Pharmaust Limited had revenue of 0.00 and earned -16.59M in profits. Earnings per share was -0.04.
Revenue0.00
Gross Profit0.00
Operating Income-18.48M
Pretax Income-16.59M
Net Income-16.59M
EBITDA-18.48M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -5.17M and capital expenditures -5.00, giving a free cash flow of -5.17M billion.
Operating Cash Flow-5.17M
Free Cash Flow-5.17M
Free Cash Flow per Share>-0.01
Dividends & Yields
Pharmaust Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change-33.80%
50-Day Moving Average0.09
200-Day Moving Average0.13
Relative Strength Index (RSI)55.10
Average Volume (3m)1.10M
Important Dates
Pharmaust Limited upcoming earnings date is Feb 26, 2026, TBA (Confirmed).
Last Earnings DateAug 25, 2025
Next Earnings DateFeb 26, 2026
Ex-Dividend Date―
Financial Position
Pharmaust Limited as a current ratio of 2.84, with Debt / Equity ratio of 0.00%
Current Ratio2.84
Quick Ratio2.84
Debt to Market Cap0.00
Net Debt to EBITDA0.23
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pharmaust Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Pharmaust Limited EV to EBITDA ratio is -3.63, with an EV/FCF ratio of -4.69.
EV to Sales0.00
EV to EBITDA-3.63
EV to Free Cash Flow-4.69
EV to Operating Cash Flow-4.69
Balance Sheet
Pharmaust Limited has AU$9.72M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$9.72M billion.
Cash & Marketable SecuritiesAU$9.72M
Total DebtAU$0.00
Net CashAU$9.72M
Net Cash Per ShareAU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Pharmaust Limited is AU$0.28, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.28
Price Target Upside180.00% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―